2021-01-01 2021-12-31 false Capium Accounts Production 1.1 10427295 bus:AbridgedAccounts 2021-01-01 2021-12-31 10427295 bus:FRS102 2021-01-01 2021-12-31 10427295 bus:AuditExemptWithAccountantsReport 2021-01-01 2021-12-31 10427295 bus:SmallCompaniesRegimeForAccounts 2021-01-01 2021-12-31 10427295 bus:PrivateLimitedCompanyLtd 2021-01-01 2021-12-31 10427295 2021-01-01 2021-12-31 10427295 2021-12-31 10427295 bus:RegisteredOffice 2021-01-01 2021-12-31 10427295 core:WithinOneYear 2021-12-31 10427295 core:AfterOneYear 2021-12-31 10427295 bus:Director1 2021-01-01 2021-12-31 10427295 bus:Director1 2021-12-31 10427295 bus:Director1 2020-01-01 2020-12-31 10427295 bus:Director2 2021-01-01 2021-12-31 10427295 bus:Director2 2021-12-31 10427295 bus:Director2 2020-01-01 2020-12-31 10427295 2020-01-01 10427295 bus:CompanySecretary1 2021-01-01 2021-12-31 10427295 bus:LeadAgentIfApplicable 2021-01-01 2021-12-31 10427295 2020-01-01 2020-12-31 10427295 2020-12-31 10427295 core:WithinOneYear 2020-12-31 10427295 core:AfterOneYear 2020-12-31 10427295 bus:EntityAccountantsOrAuditors 2020-01-01 2020-12-31 10427295 bus:OrdinaryShareClass1 2021-01-01 2021-12-31 10427295 bus:OrdinaryShareClass1 2021-12-31 10427295 bus:OrdinaryShareClass1 2020-01-01 2020-12-31 10427295 bus:OrdinaryShareClass1 2020-12-31 10427295 core:CostValuation core:Non-currentFinancialInstruments 2021-12-31 10427295 core:CostValuation core:Non-currentFinancialInstruments 2020-12-31 10427295 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2021-12-31 10427295 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2021-12-31 10427295 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2021-12-31 10427295 core:Non-currentFinancialInstruments 2021-12-31 10427295 core:Non-currentFinancialInstruments 2020-12-31 10427295 core:ShareCapital 2021-12-31 10427295 core:ShareCapital 2020-12-31 10427295 core:RetainedEarningsAccumulatedLosses 2021-12-31 10427295 core:RetainedEarningsAccumulatedLosses 2020-12-31 10427295 dpl:Item1 2021-01-01 10427295 dpl:Item1 2021-12-31 10427295 dpl:Item1 2020-01-01 10427295 dpl:Item1 2020-12-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 10427295
England and Wales

 

 

 

BIOMETRIC INNOVATIONS LIMITED


Abridged Accounts
 


Period of accounts

Start date: 01 January 2021

End date: 31 December 2021
Chartered Accountants' report to the board of directors on the preparation of the unaudited statutory accounts of Biometric Innovations Limited for the year ended 31 December 2021


In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Biometric Innovations Limited for the year ended 31 December 2021 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the companys accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales, we are subject to its ethical and other professional requirements which are detailed at www.icaew.com/en/members/regulations-standards-and-guidance This report is made solely to the Board of Directors of Biometric Innovations Limited, as a body, in accordance with the terms of our engagement letter.

Our work has been undertaken solely to prepare for your approval the accounts of Biometric Innovations Limited and state those matters that we have agreed to state to the Board of Directors of Biometric Innovations Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Biometric Innovations Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Biometric Innovations Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Biometric Innovations Limited. You consider that Biometric Innovations Limited is exempt from the statutory audit requirement for the year. We have not been instructed to carry out an audit or a review of the accounts of Biometric Innovations Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts for the year ended 31 December 2021. 



....................................................
Chawton Hector
12 Wincanton Close
Towcester
Northamptonshire
NN12 6NP

18 July 2022
1
 
 
Notes
 
2021
£
  2020
£
Current assets      
Debtors: amounts falling due within one year 4,894    1,842 
Cash at bank and in hand 153,028    360,686 
157,922    362,528 
Creditors: amount falling due within one year (6,862)   (12,819)
Net current assets 151,060    349,709 
 
Total assets less current liabilities 151,060    349,709 
Creditors: amount falling due after more than one year (1,202,328)   (1,009,427)
Net liabilities (1,051,268)   (659,718)
 

Capital and reserves
     
Called up share capital 1,000    1,000 
Profit and loss account (1,052,268)   (660,718)
Shareholder's funds (1,051,268)   (659,718)
 


For the year ended 31 December 2021 the company was entitled to exemption from audit under section 477 of the companies act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the companies act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of Part 15 of the Companies Act 2006. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).
The financial statements were approved by the board of directors on 18 July 2022 and were signed on its behalf by:


--------------------------------
David Story
Director
2
General Information
Biometric Innovations Limited is a private company, limited by shares, registered in England and Wales, registration number 10427295, registration address Hub 8 - Trust Stamp, The Brewery Quarter, Cheltenham, GL50 3FF

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. 
Going concern basis
The directors believe that the companies research and development work is going according to plan and that and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources and financial support to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Foreign currencies
Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the rate of exchange ruling at the statement of financial position date. Transactions in foreign currencies are recorded at the rate ruling at the date of the transaction. All foreign exchange differences are included to the income statement.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
2.

Average number of employees

Average number of employees during the year was 8 (2020 : 11).
3.

Share Capital

Allotted, called up and fully paid
2021
£
  2020
£
1,000 Ordinary shares of £1.00 each 1,000    1,000 
1,000    1,000 

3